World's Best Scientists 2026 revealed!
Raymond J. Bergeron

Raymond J. Bergeron

D-Index & Metrics

Biology and Biochemistry

D-Index
67
Citations
10927
World Ranking
8415
National Ranking
3788

Chemistry

D-Index
67
Citations
11116
World Ranking
7131
National Ranking
2117

Raymond J. Bergeron publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Raymond J. Bergeron sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 230 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Raymond J. Bergeron D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Raymond J. Bergeron sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 67 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Research.com Recognitions

  • 1977 - Fellow of Alfred P. Sloan Foundation

Overview

Raymond J. Bergeron is affiliated with the University of Florida in the United States. Their research spans multiple fields, primarily Medicine, Biochemistry, Genetics and Molecular Biology, and Engineering. Their work is notably interdisciplinary, bridging biological sciences and engineering principles.

The scientist's recent publications address a range of topics including cancer research, metabolic processes, and additive manufacturing technologies. The following are some examples of their published papers:

  • Targeting pheochromocytoma/paraganglioma with polyamine inhibitors, 2020, Metabolism
  • Mesoscale multilayer multitrack modeling of melt pool physics in laser powder bed fusion of lattice metal features, 2024, Additive Manufacturing
  • Niche for polyamine inhibition in treatment of metastatic pheochromocytoma and paraganglioma, 2024, European Journal of Clinical Investigation
  • MON-199 Targeting Pheochromocytoma/Paraganglioma with Polyamine Inhibitors, 2020, Journal of the Endocrine Society

Frequent publication venues for their work include:

  • Metabolism
  • Additive Manufacturing
  • European Journal of Clinical Investigation
  • Journal of the Endocrine Society

The scientist collaborates regularly with a group of coauthors, which include Heather Hatch, Karel Pacák, Sergei G. Tevosian, Hans K. Ghayee, and Fernando Bril.

Their main fields of study and subfields encompass:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology
  • Engineering
  • Neurology
  • Cancer Research
  • Surgery
  • Mechanical Engineering
  • Automotive Engineering

The primary research topics covered by this scientist focus on:

  • Neuroblastoma Research and Treatments
  • Cancer, Hypoxia, and Metabolism
  • Adrenal and Paraganglionic Tumors
  • Additive Manufacturing Materials and Processes
  • Additive Manufacturing and 3D Printing Technologies
  • Welding Techniques and Residual Stresses

In 1977, Raymond J. Bergeron was recognized as a Fellow of the Alfred P. Sloan Foundation.

Best Publications

  • Disposition requirements for binding in aqueous solution of polar substrates in the cyclohexaamylose cavity

    Raymond J. Bergeron;Michael Almy Channing;George J. Gibeily;David M. Pillor

  • Correlations between Polyamine Analogue-induced Increases in Spermidine/Spermine N1-Acetyltransferase Activity, Polyamine Pool Depletion, and Growth Inhibition in Human Melanoma Cell Lines

    Carl W. Porter;Barbara Ganis;Paul R. Libby;Raymond J. Bergeron

  • Synthetic polyamine analogues as antineoplastics.

    Raymond J. Bergeron;Allen H. Neims;James S. McManis;Thomas R. Hawthorne

  • Differential induction of spermidine/spermine N1-acetyltransferase in human lung cancer cells by the bis(ethyl)polyamine analogues.

    Robert A. Casero;Paul Celano;Stephanie J. Ervin;Carl W. Porter

  • Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators.

    S Nyholm;G J Mann;A G Johansson;R J Bergeron

  • The Development of Iron Chelators for Clinical Use

    Gary M. Brittenham;Raymond J. Bergeron

  • Antineoplastic and antiherpetic activity of spermidine catecholamide iron chelators

    Raymond J. Bergeron;Raymond J. Bergeron;Paul F. Gavanaugh;Paul F. Gavanaugh;Steven J. Kline;Steven J. Kline;Robert G. Hughes;Robert G. Hughes

  • Evaluation of desferrithiocin and its synthetic analogues as orally effective iron chelators.

    Raymond J. Bergeron;Jan Wiegand;John B. Dionis;Majia Egli-Karmakka

  • A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics.

    Raymond J. Bergeron;Yang Feng;William R. Weimar;James S. McManis

  • Spermidine requirement for cell proliferation in eukaryotic cells: structural specificity and quantitation

    Carl W. Porter;Raymond J. Bergeron

  • Total synthesis of (.+-.)-15-deoxyspergualin

    Raymond J. Bergeron;James S. McManis

  • A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine.

    Raymond J. Bergeron;Richard R. Streiff;Jan Wiegand;Gabriel Luchetta

  • Polyamine Analogue Induction of the p53-p21WAF1/CIP1-Rb Pathway and G1 Arrest in Human Melanoma Cells

    Debora L. Kramer;Slavoljub Vujcic;Paula Diegelman;James Alderfer

  • Biological properties of N4- and N1,N8-spermidine derivatives in cultured L1210 leukemia cells.

    Carl W. Porter;Paul F. Cavanaugh;Neal Stolowich;B. Ganis

  • Relative abilities of bis(ethyl) derivatives of putrescine, spermidine, and spermine to regulate polyamine biosynthesis and inhibit L1210 leukemia cell growth.

    Carl W. Porter;Jim McManis;Robert A. Casero;Raymond J. Bergeron

  • Dependence of cycloamylose-substrate binding on charge

    Raymond J. Bergeron;Michael Almy Channing;Kathy Ann McGovern

  • A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey model

    Raymond J. Bergeron;Richard R. Streiff;Elizabeth A. Creary;Richard D. Daniels

  • Antitumor activity of N,N'-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts.

    Ralph J. Bernacki;Raymond J. Bergeron;Carl W. Porter

  • Antiproliferative properties of polyamine analogues: a structure-activity study.

    Raymond J. Bergeron;James S. McManis;Charles Z. Liu;Yang Feng

  • Macromolecular Self-Assembly of Diketopiperazine Tetrapeptides

    Raymond J. Bergeron;Otto Phanstiel;Guo Wei Yao;Sam Milstein

Frequent Co-Authors

Carl W. Porter
Carl W. Porter Roswell Park Comprehensive Cancer Center
Gary M. Brittenham
Gary M. Brittenham Columbia University
Anthony E. Pegg
Anthony E. Pegg Pennsylvania State University
Robert A. Casero
Robert A. Casero Johns Hopkins University School of Medicine
Burt G. Feuerstein
Burt G. Feuerstein University of California, San Francisco
Khalil A. Abboud
Khalil A. Abboud University of Florida
Konrad Bloch
Konrad Bloch Harvard University
Paula M. Vertino
Paula M. Vertino Emory University
Robert Hromas
Robert Hromas The University of Texas Health Science Center at San Antonio

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a Chemistry degree in the USA opens doors to diverse career paths beyond traditional laboratory roles. For those interested in legal aspects related to science, exploring what types of paralegals make the most money can provide insight into specialized legal support careers that often intersect with pharmaceutical and chemical industries.

Chemistry graduates can also consider roles like pharmaceutical sales representatives. Understanding how much do drug reps make helps gauge financial potential while highlighting the importance of strong communication skills combined with scientific knowledge.

For those aiming for more technical expertise in healthcare, exploring how do you become a pharmacist outlines the necessary education and certifications required to enter this well-paying and impactful field.

Additionally, chemistry skills are highly relevant in forensic science careers such as becoming a forensic autopsy technician. Learning forensic autopsy technician roles can shed light on education requirements and job outlook for those interested in science applied to legal investigations.

Best Scientists Citing Raymond J. Bergeron

Trending Scientists

Recently Published Articles